InvestorsHub Logo
Followers 12
Posts 511
Boards Moderated 0
Alias Born 03/14/2017

Re: None

Sunday, 09/06/2020 11:05:46 PM

Sunday, September 06, 2020 11:05:46 PM

Post# of 694169
DCVAX L will be approved fro MGMT and IDH wildtype mutation. That would cover > 60% of GBM cases. Not sure about the non MGMT type. They might be the patients who will be targeted with the checkpoint inhibitor + dcvax trial to see if they would have a better result.

$NWBO $AVXL $IPIX $RLFTF $DFFN $SEEL I am going to be either too rich or too poor to visit these boards in the next 6 months.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News